Abridge AI, a startup developing software for note-taking during medical conversations, is in discussions with Andreessen Horowitz for a $300 million funding round, valuing the company at $5.3 billion. The technology aims to improve communication and record-keeping in healthcare settings between doctors and patients.
Abridge AI in Deal Talks with Andreessen Horowitz at $5.3 Billion Valuation
Abridge AI, a startup developing software for note-taking during medical conversations, is in discussions with Andreessen Horowitz for a $300 million funding round, valuing the company at $5.3 billion. The technology aims to improve communication and record-keeping in healthcare settings between doctors and patients.